Freeslate Asia High Throughput Summit Highlights Best Practices in High Throughput Research and Data Management

Share Article

R&D Leaders Share Best Practices Through Case Studies and Strategic Discussions

News Image
It is clear that companies and institutions in China are thinking about how to use advanced technology to dramatically improve the productivity of their research.

Freeslate, Inc., the leading provider of high throughput research solutions for biopharmaceutical development, today announced highlights from its Asia High Throughput Summit, held November 17, 2014 at Crystal Pharmatech in Suzhou, China. The meeting featured customer case studies and discussions of best practices in high throughput research and data management.

At this year’s Summit, academic and industry leaders in small molecule preformulation were brought together to share best practices for accelerating solubility, polymorph, crystallization, and co-crystal screens. Discussions focused on ways that science and technology can increase the productivity of R&D organizations.

As the first Freeslate Summit held in China, a key focus was discussions surrounding how laboratory automation can solve the day-to-day challenges researchers face. The Summit consisted of formal case-study presentations highlighting examples of Freeslate products and their ability to achieve dramatic innovation and rapid return on investment. A tour of Crystal Pharmatech’s facility allowed attendees to see automation tools at work and discuss specific implementation with scientists and technicians. Networking between sessions offered attendees opportunities for one-on-one discussions and to exchange new strategies and ideas.

“It is great to see the excitement and engagement around using automated systems to support the drug development process,” said John S. Senaldi, President and CEO of Freeslate. “It is clear that companies and institutions in China are thinking about how to use advanced technology to dramatically improve the productivity of their research.”

Freeslate offers unique, high throughput systems to address drug development applications. Based on the Freeslate Core Module 3 and CM Protégé automation platforms, Freeslate offers automation solutions for biologics formulation, small molecule preformulation, and process chemistry, all linked to a powerful data management suite for getting the most out of the data generated.

About Freeslate

Freeslate is a privately held company providing laboratory automation products that dramatically improve the productivity and innovation of drug development organizations. For more than a decade, Freeslate has been working with customers to automate complex chemical research processes. Our resulting product line includes solutions for protein and vaccine drug formulation development, small molecule solubility, and polymorph screening and process chemistry. We start with a scientific understanding of our customer’s bottlenecks and utilize our robust and proprietary automation platforms and integrated Lab Execution and Analysis (LEA) software suite to deliver solutions that make a difference. The company is headquartered in Sunnyvale, California, with direct sales and service in North America, Europe, and Asia. For more information, visit http://www.freeslate.com.

Share article on social media or email:

View article via:

Pdf Print

Contact Author

Mikelle Thatcher
Freeslate, Inc.
+1 (408) 773-4081
Email >
Visit website